申请人:Tomita Naoki
公开号:US20140228405A1
公开(公告)日:2014-08-14
The present invention provides a compound having a lysine-specific demethylase 1 inhibitory action, and useful as a medicament such as a prophylactic or therapeutic agent for cancer, and central nervous system diseases, and the like. The present invention relates to a compound represented by the formula
wherein A is a hydrocarbon group or heterocyclic group optionally having substituent(s); R is H, a hydrocarbon group or heterocyclic group optionally having substituent(s); A and R are optionally bonded to each other to form a ring optionally having substituent(s); Q
1
, Q
2
, Q
3
and Q
4
are each a hydrogen atom or a substituent; Q
1
and Q
2
, and Q
3
and Q
4
, are each optionally bonded to each other to form a ring optionally having substituent(s); X is H, an acyclic hydrocarbon group or saturated cyclic group optionally having substituent(s); Y
1
, Y
2
and Y
3
are each H, a hydrocarbon group or heterocyclic group optionally having substituent(s); X and Y
1
, and Y
1
and Y
2
, are each optionally bonded to each other to form a ring optionally having substituent(s); and Z
1
, Z
2
and Z
3
are each H or a substituent, or a salt thereof.
本发明提供了一种具有赖氨酸特异性去甲基化酶1抑制作用的化合物,可用作预防或治疗癌症、中枢神经系统疾病等药物。本发明涉及一种化合物,其表示为式(I):其中A是一个烃基或杂环基,可选地具有取代基;R是H、烃基或杂环基,可选地具有取代基;A和R可选地彼此连接以形成可选地具有取代基的环;Q1、Q2、Q3和Q4是每个氢原子或取代基;Q1和Q2以及Q3和Q4可选地彼此连接以形成可选地具有取代基的环;X是H、一个无环烃基或饱和环基,可选地具有取代基;Y1、Y2和Y3是每个H、烃基或杂环基,可选地具有取代基;X和Y1以及Y1和Y2可选地彼此连接以形成可选地具有取代基的环;Z1、Z2和Z3是每个H或取代基,或其盐。